Aligning manufacturers, payers and patients: Curant Health at Armada 2015

“A serious conversation about MTM is worth having, and evidence is emerging that it works.” Forbes

Prove The Value of High Cost Therapies. Drive Value for Plan Sponsors. Improve Outcomes. Improve Lives. Connect With Us Today.

Marc O'Connor speaks to Specialty Pharmacy Times editor Davy James at the 2015 Armada Specialty Pharmacy Summit: Aligning Manufacturers, PBMs and Pharmacies

Prove the value of high cost therapies.

30% – Documented adherence improvement among chronically ill patients on Curant’s medication management protocols.

90% – Current HCV 12-week cure rates.

Drive down costs for plan sponsors.

$3000 – Demonstrated savings per patient / per year in overall healthcare costs. 

Connecting us all are the patients.

69% – Curant HIV patients whose viral loads improved to undetectable.

Follow Curant Health on Twitter and LinkedIn for our take on the 2015 Armada Specialty Pharmacy Summit and other events where medication management and healthcare industry leaders connect. 

 
EmailEmailEmailEmail